287 related articles for article (PubMed ID: 26757166)
1. Alda-1 Attenuates Lung Ischemia-Reperfusion Injury by Reducing 4-Hydroxy-2-Nonenal in Alveolar Epithelial Cells.
Ding J; Zhang Q; Luo Q; Ying Y; Liu Y; Li Y; Wei W; Yan F; Zhang H
Crit Care Med; 2016 Jul; 44(7):e544-52. PubMed ID: 26757166
[TBL] [Abstract][Full Text] [Related]
2. Alda-1, an ALDH2 activator, protects against hepatic ischemia/reperfusion injury in rats via inhibition of oxidative stress.
Zhang T; Zhao Q; Ye F; Huang CY; Chen WM; Huang WQ
Free Radic Res; 2018 Jun; 52(6):629-638. PubMed ID: 29589772
[TBL] [Abstract][Full Text] [Related]
3. Pretreatment with the ALDH2 agonist Alda-1 reduces intestinal injury induced by ischaemia and reperfusion in mice.
Zhu Q; He G; Wang J; Wang Y; Chen W
Clin Sci (Lond); 2017 Jun; 131(11):1123-1136. PubMed ID: 28325855
[TBL] [Abstract][Full Text] [Related]
4. Alda-1 reduces cerebral ischemia/reperfusion injury in rat through clearance of reactive aldehydes.
Fu SH; Zhang HF; Yang ZB; Li TB; Liu B; Lou Z; Ma QL; Luo XJ; Peng J
Naunyn Schmiedebergs Arch Pharmacol; 2014 Jan; 387(1):87-94. PubMed ID: 24081521
[TBL] [Abstract][Full Text] [Related]
5. Aldehyde dehydrogenase-2 activation during cardioplegic arrest enhances the cardioprotection against myocardial ischemia-reperfusion injury.
Gong D; Zhang Y; Zhang H; Gu H; Jiang Q; Hu S
Cardiovasc Toxicol; 2012 Dec; 12(4):350-8. PubMed ID: 22814936
[TBL] [Abstract][Full Text] [Related]
6. Alda-1 Ameliorates Liver Ischemia-Reperfusion Injury by Activating Aldehyde Dehydrogenase 2 and Enhancing Autophagy in Mice.
Li M; Xu M; Li J; Chen L; Xu D; Tong Y; Zhang J; Wu H; Kong X; Xia Q
J Immunol Res; 2018; 2018():9807139. PubMed ID: 30671488
[TBL] [Abstract][Full Text] [Related]
7. Role of aldehyde dehydrogenase 2 in ischemia reperfusion injury: An update.
Panisello-Roselló A; Lopez A; Folch-Puy E; Carbonell T; Rolo A; Palmeira C; Adam R; Net M; Roselló-Catafau J
World J Gastroenterol; 2018 Jul; 24(27):2984-2994. PubMed ID: 30038465
[TBL] [Abstract][Full Text] [Related]
8. Alda-1 Prevents Pulmonary Epithelial Barrier Dysfunction following Severe Hemorrhagic Shock through Clearance of Reactive Aldehydes.
Hua T; Yang M; Zhou Y; Chen L; Wu H; Liu R
Biomed Res Int; 2019; 2019():2476252. PubMed ID: 31467875
[TBL] [Abstract][Full Text] [Related]
9. Aldehydic load and aldehyde dehydrogenase 2 profile during the progression of post-myocardial infarction cardiomyopathy: benefits of Alda-1.
Gomes KM; Bechara LR; Lima VM; Ribeiro MA; Campos JC; Dourado PM; Kowaltowski AJ; Mochly-Rosen D; Ferreira JC
Int J Cardiol; 2015 Jan; 179():129-38. PubMed ID: 25464432
[TBL] [Abstract][Full Text] [Related]
10. Pharmacological Activation Of Aldehyde Dehydrogenase 2 Protects Against Heatstroke-Induced Acute Lung Injury by Modulating Oxidative Stress and Endothelial Dysfunction.
Tsai HY; Hsu YJ; Lu CY; Tsai MC; Hung WC; Chen PC; Wang JC; Hsu LA; Yeh YH; Chu P; Tsai SH
Front Immunol; 2021; 12():740562. PubMed ID: 34764958
[TBL] [Abstract][Full Text] [Related]
11. Effects of Alda-1, an Aldehyde Dehydrogenase-2 Agonist, on Hypoglycemic Neuronal Death.
Ikeda T; Takahashi T; Tsujita M; Kanazawa M; Toriyabe M; Koyama M; Itoh K; Nakada T; Nishizawa M; Shimohata T
PLoS One; 2015; 10(6):e0128844. PubMed ID: 26083658
[TBL] [Abstract][Full Text] [Related]
12. Pretreatment with the ALDH2 activator Alda‑1 protects rat livers from ischemia/reperfusion injury by inducing autophagy.
Liu Z; Ye S; Zhong X; Wang W; Lai CH; Yang W; Yue P; Luo J; Huang X; Zhong Z; Xiong Y; Fan X; Li L; Wang Y; Ye Q
Mol Med Rep; 2020 Sep; 22(3):2373-2385. PubMed ID: 32705206
[TBL] [Abstract][Full Text] [Related]
13. Alda-1, an aldehyde dehydrogenase-2 agonist, causes deterioration in renal functions following ischemia-reperfusion injury due to crystalline nephropathy.
Hammad FT; Al-Salam S; Yuvaraju P; Lubbad L
Drug Dev Res; 2018 Nov; 79(7):315-323. PubMed ID: 30291750
[TBL] [Abstract][Full Text] [Related]
14. Aldehyde dehydrogenase 2 protects against oxidative stress associated with pulmonary arterial hypertension.
Xu T; Liu S; Ma T; Jia Z; Zhang Z; Wang A
Redox Biol; 2017 Apr; 11():286-296. PubMed ID: 28030785
[TBL] [Abstract][Full Text] [Related]
15. Activation of aldehyde dehydrogenase 2 slows down the progression of atherosclerosis via attenuation of ER stress and apoptosis in smooth muscle cells.
Yang MY; Wang YB; Han B; Yang B; Qiang YW; Zhang Y; Wang Z; Huang X; Liu J; Chen YD; Ren J; Cao F; Xu Y
Acta Pharmacol Sin; 2018 Jan; 39(1):48-58. PubMed ID: 28858301
[TBL] [Abstract][Full Text] [Related]
16. Alpha lipoic acid protects heart against myocardial ischemia-reperfusion injury through a mechanism involving aldehyde dehydrogenase 2 activation.
He L; Liu B; Dai Z; Zhang HF; Zhang YS; Luo XJ; Ma QL; Peng J
Eur J Pharmacol; 2012 Mar; 678(1-3):32-8. PubMed ID: 22266491
[TBL] [Abstract][Full Text] [Related]
17. Mitochondrial aldehyde dehydrogenase activation by Alda-1 inhibits atherosclerosis and attenuates hepatic steatosis in apolipoprotein E-knockout mice.
Stachowicz A; Olszanecki R; Suski M; Wiśniewska A; Totoń-Żurańska J; Madej J; Jawień J; Białas M; Okoń K; Gajda M; Głombik K; Basta-Kaim A; Korbut R
J Am Heart Assoc; 2014 Nov; 3(6):e001329. PubMed ID: 25392542
[TBL] [Abstract][Full Text] [Related]
18. Pharmacological enrollment of aldehyde dehydrogenase modulators to assist treating ischemia reperfusion-induced intestinal injury: is there a gap to be bridged?
Dollé L
Clin Sci (Lond); 2017 Jun; 131(11):1137-1140. PubMed ID: 28533269
[TBL] [Abstract][Full Text] [Related]
19. Pharmacological activation of aldehyde dehydrogenase 2 by Alda-1 reverses alcohol-induced hepatic steatosis and cell death in mice.
Zhong W; Zhang W; Li Q; Xie G; Sun Q; Sun X; Tan X; Sun X; Jia W; Zhou Z
J Hepatol; 2015 Jun; 62(6):1375-81. PubMed ID: 25543082
[TBL] [Abstract][Full Text] [Related]
20. Pharmacological activation of aldehyde dehydrogenase 2 promotes osteoblast differentiation via bone morphogenetic protein-2 and induces bone anabolic effect.
Mittal M; Pal S; China SP; Porwal K; Dev K; Shrivastava R; Raju KS; Rashid M; Trivedi AK; Sanyal S; Wahajuddin M; Bhaduria S; Maurya R; Chattopadhyay N
Toxicol Appl Pharmacol; 2017 Feb; 316():63-73. PubMed ID: 28017615
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
